VIVI Cap Smart transforms injectable medication protection into a connected health-data layer, enabling patients, caregivers ...

Highlighting its Proprietary INTASYL siRNA Therapeutic Platform and Development Update for Lead PH-762 Program in Cutaneous ...

ORION CORPORATION PRESS RELEASE 05 OCTOBER 2026 at 8:00am ET. Orion Pharma announces first patient dosed in Phase 1/2 ...

(NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance ...

New non-human primate data show Coave's ligand-conjugated suprachoroidal vector, coAAV-SCS, achieved up to 120-fold higher ...

Multi-year expansion of the companies’ 2025 agreement to use Gate’s Molecular Gate drug discovery engine to design molecular ...

Inducement Plan. Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious ...

Vasomune's lead therapy targeting vascular leak, for dual-use applications. TORONTO--(BUSINESS WIRE)--#ARDS--Vasomun ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to ...

In addition to the financing, Zenflow announced it has entered into an exclusive U.S. distribution agreement with Cook ...

Texas Ibogaine Research Corporation (“TIRC”), the wholly-owned Texas subsidiary of Psyence BioMed, enters manufacturing ...

Through BIO REBOOT, individuals and teams can bring research questions, technical expertise and drug discovery ideas to the ...